Showing 21 - 40 results of 84,815 for search '(( significant models based ) OR ( significant cause decrease ))', query time: 1.65s Refine Results
  1. 21
  2. 22

    Parallel bonding model. by Qingwen Li (1510687)

    Published 2025
    Subjects: “…environmental hazards caused…”
  3. 23

    Linear contact model. by Qingwen Li (1510687)

    Published 2025
    Subjects: “…environmental hazards caused…”
  4. 24

    Capsaicin, pyridoxine, vincristine sulfate and ionomycin significantly decreased axon length ratio but only pyridoxine had no impact on neurotoxicity. by Fei San Lee (17282886)

    Published 2024
    “…(<b>C</b>) Pyr at 500 μM significantly decreased axon length ratio over time and was significantly lower than PBS control by day 3. …”
  5. 25

    ATP/EMTP model and data. by Basem Abd-Elhamed Rashad (17781467)

    Published 2024
    “…<div><p>Interconnected transmission systems are increasingly spreading out in HV networks to enhance system efficiency, decrease reserve capacity, and improve service reliability. …”
  6. 26

    MAE significance comparison between MSCALSTM and baseline models based on Energy dataset. by Zhifei Yang (14613332)

    Published 2025
    “…<p>MAE significance comparison between MSCALSTM and baseline models based on Energy dataset.…”
  7. 27

    Mechanical model of geogrid element. by Qingwen Li (1510687)

    Published 2025
    Subjects: “…environmental hazards caused…”
  8. 28

    Concentrations of particles that caused significant decreases in the viability of SNU-1 cells compared to untreated cells during 1, 2, 4, 6 or 24 h treatment periods. by Amrita Banerjee (382658)

    Published 2021
    “…<p>Concentrations of particles that caused significant decreases in the viability of SNU-1 cells compared to untreated cells during 1, 2, 4, 6 or 24 h treatment periods.…”
  9. 29
  10. 30
  11. 31
  12. 32
  13. 33
  14. 34
  15. 35
  16. 36

    Swing model. by Zheng Jiang (282949)

    Published 2023
    Subjects:
  17. 37
  18. 38
  19. 39
  20. 40

    Kaplan–Meier curves for all-cause mortality. by Arisa Kobayashi (4379608)

    Published 2024
    “…Notably, the denosumab group showed a significant decrease in mortality, particularly in cardiovascular disease-related cases (HR, 0.33 [95% CI, 0.14–0.78]).…”